Fact-checked by Grok 2 weeks ago

Lhermitte's sign

Lhermitte's sign is a transient neurological symptom characterized by an electric shock-like sensation that radiates down the and into the limbs, typically triggered by flexion of the . This paroxysmal , also known as the barber chair phenomenon, is non-painful in most cases but can be startling and is often indicative of underlying in the spinal cord. First described in 1917 by Pierre Marie and Chatelin as a symptom in patients with (), it was later elaborated upon by French neurologist Jean Jacques Lhermitte in 1924, who linked it specifically to demyelination in and from whom the sign derives its name. Historically, it has been recognized as a classic but non-specific indicator of involvement, with early reports emphasizing its occurrence in inflammatory and traumatic conditions. The sign is most commonly associated with , where it affects approximately 9-41% of patients, though prevalence varies by study and disease stage. Other notable causes include spondylotic , spinal cord tumors, trauma, radiation (particularly following intensity-modulated radiation therapy for head and neck cancers), , , and nutritional deficiencies such as . In MS, it often emerges during relapses involving the cervical cord and may resolve spontaneously as subsides. Pathophysiologically, Lhermitte's sign arises from demyelination or irritation of the large-diameter sensory fibers in the (posterior) columns of the , leading to ectopic neuronal firing when these fibers are mechanically stretched during neck flexion. This hyperexcitability is exacerbated by microglial activation and ephaptic transmission between adjacent axons in the demyelinated areas. Clinically, the sensation is brief, lasting seconds, and may extend to the trunk or be elicited by other head movements like extension, though flexion is the most reliable trigger. Diagnosis relies on a detailed history and , with (MRI) of the cervical spine often revealing lesions or compression; somatosensory evoked potentials (SSEPs) can support findings of dorsal column dysfunction. Treatment focuses on addressing the underlying , such as disease-modifying therapies for or surgical for structural causes, while symptomatic relief may involve anticonvulsants like or , neck braces, or . In many cases, the sign is self-limiting and does not require intervention beyond monitoring.

Clinical Presentation

Description

Lhermitte's sign is defined as a transient, electric shock-like that radiates from the down the and into the limbs, typically elicited by flexion of the . This paroxysmal phenomenon is characterized by its brief duration, usually lasting only a few seconds, and its non-persistent nature, occurring episodically without ongoing discomfort between episodes. The sensation is often described as dysesthetic or paresthetic rather than a true , resembling a sudden jolt or tingling that travels along the posterior column pathways. Historically, it has been referred to descriptively as the "barber chair phenomenon," evoking the image of a sharp, startling feeling akin to an . While Lhermitte's sign can arise in various neurological contexts, it is most commonly associated with , where it serves as a notable clinical indicator.

Symptoms and Triggers

Lhermitte's sign manifests primarily as a sudden, transient electric shock-like sensation that originates at the occiput and radiates downward along the to the lower back, frequently extending into the , , or legs. Patients often describe this as a sharp jolt or current-like feeling, akin to an electrical discharge traveling through the body. The sensation is typically brief, lasting only a few seconds, and resolves spontaneously upon returning the to a neutral position. Variations in presentation include differences in radiation patterns, which are usually bilateral. A related variation, known as reverse Lhermitte's sign, involves an upward-radiating sensation triggered by neck extension. Intensity ranges from mild tingling or to severe, debilitating shocks that may cause patients to gasp or halt activities. While most episodes are intermittent and self-limiting, persistent symptoms are rare, with the sign generally recurring only upon provocation rather than occurring continuously. The primary trigger is forward flexion of the neck, such as when bending down to tie shoes or looking at one's feet, which stretches the spinal cord and elicits the sensation. Secondary triggers encompass coughing, sneezing, or lateral head turns, which increase intrathecal pressure or alter cord tension, as well as non-mechanical factors like , , exposure, or yawning. These provoking factors highlight the sign's paroxysmal nature and its association with demyelination in the dorsal columns of the spinal cord, particularly during acute inflammatory episodes.

History

Discovery

The initial observation of what would later become known as Lhermitte's sign occurred in 1917, when neurologists Pierre Marie and Chatelin described an electric shock-like sensation triggered by neck flexion in patients with head and cervical spine trauma sustained during . This phenomenon was noted in the context of wartime injuries, highlighting early insights into irritation, though it was not yet linked to specific demyelinating processes. In 1918, Beriel and Devic first described the sign in the context of . At the time, (MS) had been formally identified by in 1868, but detailed clinical examinations of sensory symptoms in MS were still developing, particularly as post-World War I neurology clinics in France grappled with a surge of neurological cases from combat-related injuries. Jean Lhermitte, a prominent French neurologist working in clinics such as the Salpêtrière Hospital, built on these observations through his clinical practice in the post-World War I era, where he encountered numerous patients with demyelinating diseases amid the broader advancement of neurological diagnostics. In 1924, Lhermitte published a seminal article in Revue Neurologique titled "Un cas de forme sensitive de la sclérose en plaques," detailing the sign in patients as a transient sensation elicited by cervical flexion, based on direct observations of affected individuals. These cases underscored the sign's utility as an early indicator of posterior column involvement in , marking a pivotal moment in its association with demyelination during a period when recognition was solidifying through refined clinical correlations.

Eponym and Terminology

Lhermitte's sign is an eponym honoring Jean Lhermitte (1877–1959), a prominent French neurologist known for his contributions to clinical neurology, particularly in multiple sclerosis research. Although the phenomenon was first described in 1917 by Pierre Marie and Chatelin in the context of spinal cord lesions following trauma, it was Lhermitte who systematically explored and characterized it in 1920, publishing a seminal article in 1924 that linked the symptom to demyelination in multiple sclerosis. This work elevated its recognition, leading to the eponym's adoption despite the earlier descriptions, as Lhermitte's detailed analysis established its clinical and etiological significance. The term "Lhermitte's sign" is widely used in neurological literature, but some sources prefer "Lhermitte's phenomenon" to reflect its subjective nature as a patient-reported symptom rather than an objective clinical elicited by examination. This distinction aligns with conventions, where signs are observable by clinicians and phenomena are experiential. The gained traction internationally around 1928 when introduced to American medical texts, solidifying its place despite debates over attribution priority to or Chatelin. Common synonyms include the "barber chair sign" or "barber chair phenomenon," derived from the electric shock-like sensation patients might experience when their head is tilted backward during a haircut, mimicking flexion. These alternative names emphasize the trigger mechanism but do not alter the core eponymous reference in modern , where Lhermitte's association persists due to his influential role in understanding its .

Pathophysiology

Mechanism

Lhermitte's sign is triggered by flexion of the , which mechanically stretches the dorsal columns of the spinal cord, thereby irritating demyelinated sensory fibers within these posterior structures. This stretching occurs primarily at the level of the upper cord, where the posterior aspect experiences increased tension during forward bending of the head. The mechanical imposed on the posterior structures during neck flexion leads to ectopic neural firing in the affected axons, as the demyelinated segments become susceptible to mechanical deformation. In the presence of demyelinating lesions, this disrupts the normal of fibers, allowing abnormal generation at sites of vulnerability. Electrophysiologically, the sign arises from transient in sensory afferents, driven by stretch-induced hyperexcitability of demyelinated neurons, which lowers the threshold for initiation and promotes ephaptic transmission between adjacent fibers. This hyperexcitability results in paroxysmal bursts of activity that propagate along the sensory pathways, manifesting as the characteristic shock-like sensation.

Neurological Basis

Lhermitte's sign primarily arises from demyelination or damage in the posterior () columns of the , particularly at levels to C5. These columns, consisting of the fasciculus gracilis and fasciculus cuneatus, contain large-diameter myelinated sensory fibers that transmit proprioceptive and vibratory signals from the body to the brain. The pathological changes involve loss of sheaths around these axons, which exposes them to mechanical stress during movements such as flexion. This demyelination leads to increased neuronal hyperexcitability and ephaptic , where electrical impulses cross between adjacent demyelinated fibers, generating abnormal sensory signals. Supporting evidence comes from radiographic studies of patients, where lesions in the posterior columns of the cord strongly correlate with the presence of Lhermitte's sign, confirming the anatomical basis. Although direct studies are limited, pathological examinations in cases have shown plaque formations in these regions aligning with symptom occurrence. The sign's elicitation involves brief stretching of these vulnerable structures during head flexion.

Associated Conditions

Demyelinating Diseases

Lhermitte's sign exhibits the strongest association with multiple sclerosis (MS), the most common primary demyelinating disease of the central nervous system, where it arises from demyelination and inflammation in the posterior columns of the cervical spinal cord. Prevalence among MS patients ranges from approximately 10% to 40%, with studies reporting figures such as 33% in a cohort of 114 patients and 16% in a larger reassessment of 694 cases, often manifesting early in relapsing-remitting MS during initial episodes or relapses. This symptom typically reflects irritation of demyelinated axons, exacerbated by neck flexion, and tends to be transient, resolving as inflammation subsides. The sign also occurs in (NMOSD), another immune-mediated demyelinating condition characterized by longitudinally extensive and similar spinal cord lesions affecting the . Prevalence in NMOSD is higher than in MS, with one study documenting 20.5% of patients experiencing it compared to 4.3% in MS, while other reports indicate rates up to 35-60%, underscoring the role of aquaporin-4 antibody-associated cord pathology. These lesions, often more extensive than those in MS, contribute to the electric shock-like sensations triggered by head movement. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is another demyelinating disorder linked to Lhermitte's sign, particularly in cases involving transverse myelitis with dorsal column involvement. While prevalence data are limited due to fewer studies, it has been reported in MOGAD patients with spinal cord inflammation, often presenting similarly to NMOSD but with potentially better recovery outcomes. Subacute combined degeneration of the spinal cord, resulting from vitamin B12 deficiency, represents another demyelinating-like process where Lhermitte's sign can emerge, mimicking MS through vacuolar myelopathy and posterior column involvement. This nutritional deficiency leads to impaired myelin synthesis and axonal degeneration, particularly in the dorsal and lateral columns, with case reports highlighting the sign as an initial presentation reversible upon B12 supplementation. In , Lhermitte's sign carries prognostic implications by signaling active cord , often correlating with gadolinium-enhancing lesions on MRI and potentially heralding impending exacerbations in relapsing-remitting disease. Its emergence underscores ongoing demyelinating activity, prompting evaluation for disease-modifying therapies to mitigate progression.

Other Causes

Lhermitte's sign can arise from mechanical compression of the spinal cord due to degenerative conditions such as spondylosis or , where osteoarthritic changes lead to narrowing of the and irritation of column fibers upon neck flexion. In these cases, the sign results from stretch-induced dysfunction in the compressed cord segments, often presenting in older adults with chronic and . Transverse myelitis, an inflammatory disorder of the , can also cause Lhermitte's sign through acute inflammation and demyelination affecting the columns; it may occur idiopathically, post-infectious, or as part of other autoimmune processes. Post-traumatic etiologies include injuries or direct , where the sign may emerge delayed after the initial event, even without overt neurological deficits, due to subclinical demyelination or axonal stretch in the cervical region. injuries can similarly provoke the symptom as a , reflecting ongoing sensitivity in the columns from the mechanical insult. Iatrogenic causes encompass radiation myelopathy following therapeutic of the or upper chest, typically manifesting weeks to months post-treatment as a transient electric shock sensation from temporary demyelination in the cord. Chemotherapy agents, particularly platinum-based compounds like or , may induce the sign through neurotoxic effects on sensory pathways, often resolving after discontinuation but highlighting dose-dependent vulnerability. Rare non-demyelinating associations include intramedullary tumors such as , which can present with Lhermitte's sign due to tumor-induced distortion and secondary demyelination of column axons, typically progressing with tumor growth. Arnold-Chiari malformation may elicit the symptom through caudal of cerebellar tonsils causing cord traction, often chronic and worsening with posture changes. In , an inflammatory vasculopathy, the sign arises from neuro-Behçet involvement of the , potentially transient during acute flares but indicative of underlying . These rare causes underscore the importance of to differentiate from demyelinating processes like .

Diagnosis

Clinical Evaluation

The clinical evaluation of Lhermitte's sign begins with a straightforward bedside test performed during the . The patient is typically seated comfortably, and the clinician instructs them to slowly flex the forward, bringing the toward the chest, while observing for any reported or visible reactions such as flinching. A positive response is indicated by the patient's report of a transient, electric shock-like sensation radiating down the and into the , which typically lasts only a few seconds. This sign demonstrates variable sensitivity and specificity depending on the underlying condition. In patients with multiple sclerosis (MS), the prevalence ranges from 9% to 41%, with one study reporting an incidence of 16% among approximately 700 individuals, reflecting its elicitation in a subset of affected patients but not as a universal feature. Overall, it lacks high specificity for MS alone, though it shows 97% specificity for compressive myelopathy in broader neurological contexts. Within the broader , Lhermitte's sign is integrated as part of sensory testing for suspected , often alongside assessments of deep tendon reflexes, coordination, and to evaluate dorsal column function and overall integrity. The test is particularly relevant when cord involvement is suspected, helping to localize potential lesions without requiring additional . Evaluation also incorporates patient history to contextualize the finding, with clinicians querying symptoms suggestive of MS such as prior , gait disturbances, or sensory changes like , which may correlate with the sign's presence and guide further diagnostic considerations. Triggers like neck movements or reported in the history can enhance the test's interpretive value during elicitation.

Imaging and Tests

Magnetic resonance imaging (MRI) of the cervical spine serves as the gold standard for evaluating the underlying causes of Lhermitte's sign, revealing structural abnormalities such as demyelinating plaques or compressive lesions. In (MS), MRI typically demonstrates T2-hyperintense lesions in the dorsal columns of the cervical spinal cord, present in approximately 95% of patients exhibiting the sign compared to 52% without it. For cervical spondylosis, imaging may show due to degenerative changes like disc herniation or osteophytes. Cerebrospinal fluid (CSF) analysis is often performed to support the diagnosis of associated demyelinating diseases, particularly , where are detected in the majority of cases, indicating intrathecal immunoglobulin production. Blood tests for levels are essential when deficiency is suspected, as subacute combined degeneration can mimic demyelinating pathology and the sign, with low levels confirming the . Somatosensory evoked potentials (SSEPs) assess central conduction delays, showing prolonged latencies in the and tibial nerves that correlate with demyelinating lesions in patients with Lhermitte's sign. If MRI is contraindicated, such as in patients with pacemakers, computed tomography () myelography can visualize spinal cord or abnormalities as an alternative. (EMG) may be used to exclude peripheral nerve involvement, particularly if symptoms suggest rather than central . In differentiating demyelinating causes, MRI lesion characteristics are key: short-segment lesions (spanning 1-2 vertebral segments) in the cord favor , whereas longitudinally extensive lesions (≥3 segments) suggest (NMOSD). Emerging tools are being developed to analyze MRI characteristics and predict Lhermitte's sign in patients, as of 2025.

Management

Treatment of Underlying Cause

The primary approach to managing Lhermitte's sign involves addressing the underlying to prevent progression and promote of the neurological dysfunction. In cases associated with (), disease-modifying therapies (DMTs) are employed to mitigate demyelination and reduce activity in the cervical spinal cord, where plaques often correlate with the sign's presence in up to 95% of affected patients. Examples of DMTs used in , which may indirectly benefit symptoms like Lhermitte's sign by managing the disease, include injectable interferons such as , which decrease relapse rates and slow disability progression by modulating immune responses, and monoclonal antibodies like ocrelizumab, which target CD20-positive B cells to suppress inflammatory activity and formation on MRI. For acute relapses that may exacerbate the sign, high-dose intravenous corticosteroids, such as , are administered to accelerate recovery by reducing edema around active lesions. For Lhermitte's sign stemming from , which can lead to subacute combined degeneration of the , prompt supplementation is essential to halt demyelination and restore integrity. Initial typically involves intramuscular injections of (1 mg daily for the first week, followed by weekly doses), which effectively replenishes stores and reverses neurological symptoms, including the sign, in responsive cases. Oral high-dose (1-2 mg daily) may be used for maintenance once levels normalize, particularly in or dietary deficiency etiologies. In compressive etiologies, such as spondylotic or , surgical intervention targets the mechanical irritation of the dorsal columns to alleviate the sign and prevent irreversible damage. Procedures like or anterior with fusion decompress the , often leading to rapid symptom resolution; for instance, in cases, postoperative improvement of Lhermitte's sign has been observed within days. For radiation-induced , adjusting radiation dosing protocols in ongoing or future treatments minimizes further cord injury, though established cases may require supportive measures alongside etiology-specific care. Across etiologies, serial MRI of the cervical spine is crucial for monitoring treatment efficacy, allowing visualization of lesion resolution, reduced gadolinium enhancement in MS plaques, or decompression outcomes, thereby guiding adjustments to therapy and correlating with clinical improvement in the sign. In refractory scenarios, brief reference to symptomatic options may complement these targeted interventions.

Symptomatic Relief

Symptomatic relief for Lhermitte's sign focuses on alleviating the transient electric shock-like sensations through medications that target and neural hyperexcitability, particularly when the underlying condition is stable or treatment is ongoing. First-line pharmacological options include anticonvulsants such as and , which help stabilize neuronal membranes and reduce paroxysmal symptoms. Carbamazepine is typically initiated at 200-400 mg twice daily, titrated up to 600-1200 mg per day based on response and tolerance, and has demonstrated rapid symptomatic improvement in small case series of patients experiencing Lhermitte's sign. , another modulator, is commonly dosed at 300-1200 mg three times daily, providing relief by dampening aberrant nerve firing, though individual responses vary. Alternatives like may be considered for better tolerability. These agents are preferred due to their efficacy in paroxysmal neuropathic symptoms associated with demyelination. For patients with prominent neuropathic pain components or inadequate response to anticonvulsants, tricyclic antidepressants such as amitriptyline (starting at 10-25 mg at bedtime, up to 75-150 mg daily) may be considered to modulate pain pathways, though evidence is more general to multiple sclerosis-related dysesthesias rather than Lhermitte's sign specifically. Opioids are generally avoided due to their limited efficacy in and risk of short-term relief followed by tolerance. Non-pharmacological strategies include to strengthen neck muscles and improve , thereby stabilizing the and minimizing symptom triggers like forward flexion. Patients are advised to avoid provocative movements, and has shown anecdotal benefits for overall pain, though controlled evidence for Lhermitte's sign remains limited. Symptomatic treatments can integrate with disease-modifying therapies to enhance without addressing the root . A of observational data from over 450 patients indicates variable symptomatic improvement with and , often in small-scale studies lacking randomized controls. Common side effects include , , and gastrointestinal upset, necessitating monitoring and dose adjustments, particularly in older adults or those with comorbidities.

References

  1. [1]
    Lhermitte Sign - StatPearls - NCBI Bookshelf - NIH
    Jul 21, 2023 · This article reviews one of the paroxysmal symptom/pain syndromes, Lhermitte's sign, a transient electric shock sensation down the spine and ...Continuing Education Activity · Introduction · Etiology · Epidemiology
  2. [2]
    Lhermitte's Sign: The Current Status - PMC - NIH
    This sensation occurs when the neck is moved in a wrong way or rather flexed. It can also travel down to the spine, arms, and legs, and sometimes the trunk.
  3. [3]
    Multiple sclerosis - Symptoms and causes - Mayo Clinic
    Nov 1, 2024 · Electric-shock sensations that happen with certain neck movements, especially bending the neck forward. This sensation is called Lhermitte sign.
  4. [4]
    Lhermitte Sign - PubMed
    Jul 21, 2023 · Lhermitte's sign (also known as Lhermitte's phenomenon or the barber chair phenomenon) is the term used that describes a transient sensation of an electric ...
  5. [5]
    Lhermitte's Sign——A Neuropathic Pain and Its Neuroanatomy - PMC
    Oct 8, 2024 · It is a type of neuropathic pain characterised by a transient sensation of electric shock from the head down the spine and occasionaly through ...Missing: definition | Show results with:definition
  6. [6]
    Lhermitte's Sign: What It Is, Causes & Treatment - Cleveland Clinic
    You might feel this sensation when you tilt your head forward, cough or sneeze. It only lasts for a few seconds at a time, but can occur many times per day.
  7. [7]
    Lhermitte's Sign: From Observation to Eponym | JAMA Neurology
    The Lhermitte's sign was first described by Pierre Marie and Chatelin ... Olkon DM: Subacute combined degeneration of the spinal cord with the symptom ...
  8. [8]
    Lhermitte's Sign. From Observation to Eponym - PubMed
    The Lhermitte's sign was first described by Pierre Marie and Chatelin in 1917. Lhermitte reported on this symptom in 1920, and in 1924 he published the ...
  9. [9]
    MS: The Basic Facts - PMC - PubMed Central - NIH
    MS was recognized in England by Dr. William Moxon in 1873, and in the United States by Dr. Edward Seguin in 1878. By the end of the century, much of what can be ...
  10. [10]
    Jean Lhermitte • LITFL • Medical Eponym Library
    Apr 13, 2022 · Initially described by Babinski, Lhermitte regarded the sign as diagnostic of multiple sclerosis. However, any cervical cord lesion ...Biography · Medical Eponyms · Major Publications
  11. [11]
    [PDF] Lhermitte's Sign A Neuropathic Pain and Its Neuroanatomy
    Jul 14, 2024 · The efferent pathway involves the primary somatosensory cortex sending signals down to the periaqueductal gray and then to the rostral.
  12. [12]
    Anatomic-radiologic basis of Lhermitte's sign in multiple sclerosis
    The findings confirm the presumption that a lesion in the posterior columns of the cervical spinal cord is the cause of Lhermitte's sign in multiple sclerosis.Missing: autopsy | Show results with:autopsy
  13. [13]
    Lhermitte's sign in multiple sclerosis: a clinical survey and review of ...
    Lhermitte's sign was experienced by 33.3% of 114 patients with multiple sclerosis, and in 16% it occurred in the first episode.
  14. [14]
    Reassessment of Lhermitte's sign in multiple sclerosis - PubMed
    One hundred and twelve (16 %) patients were reported to have Lhermitte's sign; 582 (84 %) patients did not experience Lhermitte's sign during their disease ...Missing: prevalence | Show results with:prevalence
  15. [15]
    Prevalence of Lhermitte's sign in multiple sclerosis versus ...
    The sign refers to a transient electric-shock like sensation and sometimes tingling or buzzing in the neck that runs down the spine and into limbs.Missing: definition | Show results with:definition
  16. [16]
    Pain in NMOSD and MOGAD: A Systematic Literature Review of ...
    Lhermitte's sign is often painful and occurs in 35–60% of AQP4-Ab-positive NMOSD patients (27, 81, 124). It is defined as a brief, electric-shock-like ...
  17. [17]
    Lhermitte's sign as the presenting symptom of vitamin B12 deficiency
    Lhermitte's sign as the presenting symptom of vitamin B12 deficiency. ... Gautier-Smith P. C. Lhermitte's sign in subacute combined degeneration of the cord.
  18. [18]
    Lhermitte's Sign in Cobalamin (Vitamin B12) Deficiency
    ... first described by Marie and Chatelin in 1917.1 In 1924, Lhermitte et al. ... 4. Gautier-Smith PC: Lhermitte's sign in subacute combined degeneration of the cord ...
  19. [19]
    Lhermitte's Phenomenon as the Presenting Symptom of Vitamin B12 ...
    Nov 1, 2025 · It reflects posterior column involvement and is most often associated with demyelinating diseases, though metabolic causes such as B12 ...
  20. [20]
    Lhermitte Sign as a Presenting Symptom of Thoracic Spinal Pathology
    Lhermitte sign was originally described in 1924 as a symptom consisting of an electric shock-like sensation radiating down the spine when the neck is flexed.Missing: definition | Show results with:definition
  21. [21]
    Delayed onset of Lhermitte's sign following head and/or ... - PubMed
    The authors report four patients who suffered the delayed onset of Lhermitte's sign following head and/or neck trauma with no significant neurological deficits.
  22. [22]
    Lhermitte's Syndrome After Chemo-IMRT of Head and Neck Cancer
    Aug 1, 2013 · Lhermitte's syndrome (LS) is an electric shock-like sensation in the spine and extremities exacerbated by neck flexion. It is caused by ...<|control11|><|separator|>
  23. [23]
    Isolated Oxaliplatin Induced Lhermitte's sign in Rectal Cancer (P16 ...
    May 3, 2022 · Lhermitte's sign in cancer patients can be associated with radiotherapy and chemotherapy, with cisplatin being the most common causative agent.
  24. [24]
    Lhermitte's sign as a presenting symptom of primary spinal cord tumor
    The sensory phenomena of Lhermitte's sign were most likely caused by tumor-induced distortion and demyelination of cervical dorsal column sensory axons.Missing: Arnold- Chiari Behçet's disease
  25. [25]
    Lhermitte's sign in Behçet's Disease - Oxford Academic
    C. FALGÁ-TIRADO, J. ORDI-ROS, P. PEREZ-PEMAN, E. CUCURULL-CANOSA, J. BOSCH-GIL; Lhermitte's sign in Behçet's Disease, British Journal of Rheumatology, Volu.
  26. [26]
    Lhermitte's Sign
    ### Summary of Lhermitte's Sign Evaluation
  27. [27]
    Lhermitte sign (spinal cord) | Radiology Reference Article
    Jan 13, 2025 · Lhermitte sign or the barber chair phenomenon is an electrical shock sensation running down the spine and into the limbs upon neck flexion.
  28. [28]
    Oligoclonal bands in multiple sclerosis cerebrospinal fluid - PubMed
    Two or more oligoclonal IgG bands (OB) detected by separation of cerebrospinal fluid (CSF) proteins while not demonstrable in corresponding serum reflect a ...
  29. [29]
    Lhermitte's sign and vitamin B12 deficiency: case report - PMC - NIH
    Lhermitte's sign, a classical neurological sign, is a rare manifestation of vitamin B12 deficiency. The aim here was to report on a case of an elderly patient ...
  30. [30]
    Management of Lhermitte Sign - Dr.Oracle
    Sep 25, 2025 · MRI of the brain should also be performed to evaluate for demyelinating diseases; If MRI is contraindicated, CT myelography may be considered ...
  31. [31]
    systematic approach to differentiating intramedullary spinal cord ...
    Jun 12, 2018 · MS lesions involve short segments (1–2 vertebral bodies), whereas in NMOSD, long segment and central involvement is more characteristic [11]. MS ...Demyelination · Neuromyelitis Optica... · Vascular Lesions<|control11|><|separator|>
  32. [32]
    Neuromyelitis optica spectrum disorder | Radiology Reference Article
    Oct 29, 2025 · Spinal cord involvement is extensive, typically with a high T2 signal spanning at least three vertebral segments, known as a longitudinally ...
  33. [33]
    Multiple sclerosis - Diagnosis and treatment - Mayo Clinic
    ### Summary of Disease-Modifying Therapies (DMTs) for Multiple Sclerosis and Relation to Lhermitte's Sign
  34. [34]
    Multiple sclerosis-induced neuropathic pain: pharmacological ...
    Nov 14, 2013 · We review research to date on the pathophysiological mechanisms underpinning MS-associated neuropathic pain as well as the pharmacological management of this ...
  35. [35]
    A systematic review of the symptomatic management of Lhermitte's ...
    The most commonly used agents to treat patients with LP were carbamazepine and gabapentin, which resulted in variable degrees of symptomatic benefit.Missing: relief sign trials
  36. [36]
    Understanding and Managing Pain in Multiple Sclerosis
    A: Lhermitte's phenomenon is a sudden sensation of electrical shock that spreads through the body on flexion of the neck, occurs in 25-33% of patients with MS.
  37. [37]
    Carbamazepine: A Symptomatic Treatment of the Paresthesiae ...
    Carbamazepine in a rather small dosage had an immediate symptomatic effect on the paresthesiae associated with Lhermitte's sign in three patients with multiple ...
  38. [38]
    What is Lhermitte's syndrome (also known as Lhermitte's sign or ...
    Apr 3, 2025 · Anti-seizure medications like carbamazepine (200-400 mg twice daily) or gabapentin (300-1200 mg three times daily) can provide symptomatic ...
  39. [39]
    Lhermitte's sign - MS Trust
    Feb 7, 2024 · Lhermitte's sign is an electric shock-like feeling that runs down your spine from top to bottom. You may find it continues into your arms and legs.
  40. [40]
    A systematic review of the symptomatic management of Lhermitte's ...
    Lhermitte's phenomenon (LP) is a transient shock-like sensation that radiates down the spine into the extremities, usually with neck flexion.
  41. [41]
    MS pain | Understanding pain in multiple sclerosis - MS Trust
    Lhermitte's sign, electric shock feelings in the neck and spine which are sometimes painful ... There is some evidence that acupuncture can help MS pain.